1 Tvardi Therapeutics Inc Receivables Turnover Ratio (TVRD), from the second quarter 2026 to the second quarter 2025 current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Tvardi Therapeutics Inc   (NASDAQ: TVRD)
 

Tvardi Therapeutics Inc Accounts Receivables Turnover Ratio from the second quarter 2026 to the second quarter 2025

Quarterly Results, Trends, Rankings, Statistics


According to Tvardi Therapeutics Inc Balance Sheet, in the second quarter 2026, company has not reported any Accounts receivable.
See Tvardi Therapeutics Inc Balance Sheet

If we take a look into Healthcare sector Tvardi Therapeutics Inc achieved the highest receivable turnover ratio. While receivables turnover ratio remained unchanged relative to the previous period at no. .

What is Receivable Turnover Ratio?
What is Tvardi Therapeutics Inc Selling?


What is Receivable Turnover Ratio?




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

TVRD Receivables Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Receivable Change - - - - -
Y / Y Revenue Change - - - - -
Receivable Turnover Ratio (TTM) - - 4.59 2.39 3.25
TVRD's Total Ranking # # # # #
Accounts Receivable average collection period days - - 79 153 112
Seq. Receivable Change - - - - -
Seq. Revenue Change - - - - -


Receivable Turnover Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall Market #

Receivable Turnover Ratio Statistics
High Average Low
0 0 0
 




  News about Tvardi Therapeutics Inc Receivables Turnover Ratios

Tvardi Therapeutics Provides Update on Preliminary Data from Phase 2 REVERT Trial in Idiopathic Pulmonary Fibrosis

Novel Insights into Idiopathic Pulmonary Fibrosis: Tvardi Therapeutics Advances with Promising Phase 2 Trial Results for TTI-101In the ever-evolving landscape of therapeutics for fibrotic diseases, Tvardi Therapeutics, Inc. (NASDAQ: TVRD) is making significant strides in addressing the challenges posed by idiopathic pulmonary fibrosis (IPF). The Houston-based clinical-stage biopharmaceutical company specializes in developing innovative, oral small molecule therapies aimed at targeting STAT3 a pivotal player in the fibrotic process.Recently, Tvardi provided updates from its Phase 2 clinical trial known as REVERT , which focuses on the efficacy and safety of TTI-101 , its lead compound, in patients diagnosed with IPF. This open-label study is particularly noteworthy as it explores the therapeutic potential of TTI-101 in a randomized, double-blind, placebo-controlled design, a rigorously structured approach that increases the reliability of the findings.


TVRD Company Profile • Back to TVRD Efficiency Comparisons • Compare TVRD Receivables Turnover Ratio to its Competitors

Financial Statements
Tvardi Therapeutics Inc 's Accounts Receivable $ 0 Millions Visit TVRD's Balance sheet
Tvardi Therapeutics Inc 's Sales TTM $ 0 Millions Visit TVRD's Income Statement
Sources of TVRD's Revenues Visit TVRD's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
TVRD's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
TVRD's Growth Rates TVRD's Roa TVRD's Inventory Turnover Ratio TVRD's Dividend Comparisons
TVRD's Profitability Ratios TVRD's Roi TVRD's Asset Turnover Ratio TVRD's Dividend Growth
TVRD's Valuation Ratios TVRD's Roe TVRD's Financial Strength Ratios TVRD's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Jun 30 2026 Receivable at quarter ending Jun 30 2026

Date modified: 2026-08-16T09:11:01+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.